Frontlight ResearchEarly access
CompletedNo phase
Alpha-lipoic Acid in Critically Ill Patients With Sepsis
Key facts
- Who runs it
- Damanhour University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 80 people enrolled
- Started
- 15 Oct 2024
- Ended
- 28 Oct 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Placebo
- Alpha-lipoic acid
- Record updated
- 22 April 2026
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patients who will be diagnosed with sepsis or develop sepsis during their ICU length of stay
- Age 18 year and older
- Patient able to receive oral or enteral medication
Who cannot take part
- Current treatment with other medications that have antioxidant effects, such as vitamin C and vitamin E
- Allergy to LA or similar active agents (e.g., vitamin B), or previous intolerance to the recommended dose of LA
- Patients who will be diagnosed with septic shock
- Female patients who are pregnant or lactating
- Participation in another clinical trial
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Evaluate the of effect of alpha-lipoic acid in critically ill septic patients. 80 septic patients will be enrolled from Damanhur National medical institute, and they will be randomized using simple randomization into control group will receive placebo and ALA group will be given 1800 mg orally or via a nasogastric tube of ALA daily for seven days .
The 2 groups in the trial
- Placebo GroupPlacebo, for comparison
control group: 40 septic patients will receive placebo daily for seven days.
Treatment: Placebo
- ALA groupExisting treatment, for comparison
ALA group: 40 septic patients will be given 1800 mg for seven days .
Treatment: Alpha-lipoic acid
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Alpha-lipoic Acid in Critically Ill Patients With Sepsis
- Record updated
- 22 April 2026